3077 65 plus: A randomized phase III trial of Pemetrexed and Bevacizumab vs. Pemetrexed, Bevacizumab and Carboplatin as 1st line treatment for elderly patients with advanced non-squamous, non-small cell lung cancer (NSCLC) - a subgroup analysis of age and gender. (September 2015) - Schuette, W.; Nieman, B.; Schneider, C.P.; Engel-Riedel, W.; Schumann, C.; Kohlhaeufl, M.; Serke, M.; Hoeffken, G.; Kortsik, C.; Reck, M.